The clinical utility of flow cytometry in the study of platelets

Seminars in Hematology

Volumn 38, Issue 2, 2001, Pages 160-168

  Ault, Kenneth A ^a,b  

^a Maine Medical Center Research Institute   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLOW CYTOMETRY; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

EID: 0035063311     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(01)90049-6     Document Type: Article

References (49)

1. Immunological detection of activated platelets in clinical disorders
2. Direct detection of activated platelets and platelet derived microparticles in human blood
3. Implementation of the immunological platelet count on a hematology analyzer - The Abbott CELL-DYN 4000
4. Flow cytometric measurement of platelet-associated immunoglobulin
5. Platelet counting: Is there room for improvement?
6. Platelet activation in patients after an acute coronary syndrome: Results from the TIMI-12 trial. Thrombolysis in myocardial infarction
7. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation
8. Genetic control of platelet activation in inbred mouse strains
9. Analysis of platelets by flow cytometry
10. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis
11. Correlated measurement of platelet release and aggregation in whole blood
12. Dynamic nature of thrombin generation, fibrin formation, and platelet activation in unstable angina and non-Q-wave myocardial infarction
13. Spontaneous platelet activation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure
14. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: Results from TIMI (thrombolysis in myocardial infarction) 14
15. Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old
16. Indirect immunoplatelet counting by flow cytometry as a reference method for platelet count calibration
17. P-selectin mediates Ca+2 dependent adhesion of activated platelets to many different types of leukocytes: Detection by flow cytometry
18. Platelet/ polymorphonuclear leukocyte interaction in dynamic conditions: Evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD1lb/CD18
19. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis
20. P-selectin induction of tissue factor biosynthesis and expression
21. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease
22. GMP-140 mediates adhesion of stimulated platelets to neutrophils
23. Immunoplatelet counting: A proposed new reference procedure
24. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia
25. Reticulated platelets following acute blood loss
26. Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry
27. Flow cytometric analysis of thiazole orange uptake by platelets: A diagnostic aid in the evaluation of thrombocytopenic disorders
28. PTCA: Periprocedural platelet activation. Part II of the Duesseldorf PTCA Platelet Study (DPPS)
29. A diagnostic test for heparin-induced thrombocytopenia: Detection of platelet microparticles using flow cytometry
30. Flow cytometric analysis of platelet surface antigens
31. Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry
32. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function
33. Laboratory markers of platelet activation and their clinical significance
34. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin
35. Improved sensitivity in flow cytometric intracellular ionized calcium measurement using Fluo-3/Fura Red fluorescence ratios
36. Markers of platelet activation in coronary heart disease patients
37. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor
38. Platelet activation and aggregation during cardiopulmonary bypass
39. Activated and unactivated platelet adhesion to monocytes and neutrophils
40. Dynamics of leukocyte-platelet adhesion in whole blood
41. Reticulated platelets in the evaluation of thrombopoietic disorders
42. Progressive platelet activation with storage: Evidence for shortened survival of activated platelets after transfusion
43. Flow cytometric analysis of reticulated platelets: Evidence for a large proportion of non-specific labelling of dense granules by fluorescent dyes
44. Detection of activated platelets in whole blood using activation dependent monoclonal antibodies and flow cytometry
45. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity
46. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity
47. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA
48. A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents
49. Red-cell and platelet fragmentation in idiopathic autoimmune thrombocytopenic purpura